Estimating Burden and Disease Costs of Exposure to Endocrine-Disrupting Chemicals in the European Union

Abstract

EDC exposures in the EU are likely to contribute substantially to disease and dysfunction across the life course with costs in the hundreds of billions of Euros per year. These estimates represent only those EDCs with the highest probability of causation; a broader analysis would have produced greater estimates of burden of disease and costs.